ID

4881

Description

ODM derived from http://clinicaltrials.gov/show/NCT00261352

Link

http://clinicaltrials.gov/show/NCT00261352

Keywords

  1. 2/24/12 2/24/12 -
  2. 4/13/14 4/13/14 - Julian Varghese
Uploaded on

April 13, 2014

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00261352 Type 2 Diabetes

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Men or women who are >=18 years of age
Description

Age

Data type

boolean

Provision of a written informed consent
Description

informed consent

Data type

boolean

Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control
Description

Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a method of birth control

Data type

boolean

Diagnosed with type 2 diabetes
Description

type 2 diabetes

Data type

boolean

Treated with diet alone or treatment with a single oral antidiabetic agent or low doses of two oral antidiabetic agents
Description

Treatment with diet alone or with a single oral antidiabetic agent or two oral antidiabetic agents

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Type 1 diabetes
Description

Type 1 diabetes

Data type

boolean

New York Heart Association heart failure Class III or IV
Description

NYHA Class III or IV

Data type

boolean

Treatment with chronic insulin
Description

Treatment with insulin

Data type

boolean

History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)
Description

hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist, fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

Data type

boolean

History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)
Description

drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia

Data type

boolean

Creatinine levels above the normal range
Description

Creatinine levels abnormal

Data type

boolean

Received any investigational product in other clinical studies within 12 weeks
Description

Received any investigational product in other clinical studies

Data type

boolean

Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study
Description

Any clinically significant abnormality, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study

Data type

boolean

Medical Concepts
Description

Medical Concepts

Age
Description

Age

Data type

integer

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
397669002
Diagnosis
Description

Diagnosis

Data type

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Informed Consent
Description

Informed Consent

Data type

string

Alias
UMLS CUI
C0021430
Postmenopausal period
Description

Postmenopause

Data type

string

Alias
UMLS CUI
C0206159
MedDRA 13.1
10051775
Hysterectomy
Description

Hysterectomy

Data type

string

Alias
UMLS CUI
C0020699
SNOMED CT 2010_0731
236886002
MedDRA 13.1
10021151
Contraception
Description

Contraception

Data type

string

Alias
UMLS CUI
C0700589
SNOMED CT 2010_0731
146680009
MedDRA 13.1
10010808
Diabetes Mellitus, Non-Insulin-Dependent
Description

Diabetes mellitus type 2

Data type

string

Alias
UMLS CUI
C0011860
SNOMED CT 2010_0731
44054006
MedDRA 13.1
10012613
ICD-10-CM Version 2010
E08-E13
Diet
Description

Diet

Data type

string

Alias
UMLS CUI
C0012155
SNOMED CT 2010_0731
41829006
Anti-diabetic Agent
Description

Anti-diabetic Agent

Data type

string

Alias
UMLS CUI
C0935929
SNOMED CT 2010_0731
373245004
Diabetes Mellitus, Insulin-Dependent
Description

Diabetes mellitus type 1

Data type

string

Alias
UMLS CUI
C0011854
SNOMED CT 2010_0731
46635009
MedDRA 13.1
10067584
LOINC Version 232
MTHU020217
ICD-10-CM Version 2010
E10
Heart failure
Description

Heart failure

Data type

string

Alias
UMLS CUI
C0018801
SNOMED CT 2010_0731
155374007
MedDRA 13.1
10019279
ICD-9-CM Version 2011
428
CTCAE Version 4.03
E10124
New York Heart Association Class III
Description

NYHA Class III

Data type

string

Alias
UMLS CUI
C1319795
SNOMED CT 2010_0731
420913000
MedDRA 13.1
10064081
New York Heart Association Class IV
Description

NYHA Class IV

Data type

string

Alias
UMLS CUI
C1319796
SNOMED CT 2010_0731
422293003
MedDRA 13.1
10064082
Therapeutic Insulin
Description

Therapeutic Insulin

Data type

string

Alias
UMLS CUI
C0557978
Insulin
Description

Insulin

Data type

string

Alias
UMLS CUI
C0021641
SNOMED CT 2010_0731
67866001
LOINC Version 232
MTHU002108
chronic
Description

chronic

Data type

string

Alias
UMLS CUI
C0205191
SNOMED CT 2010_0731
90734009
Hypersensitivity
Description

Allergy

Data type

string

Alias
UMLS CUI
C0020517
SNOMED CT 2010_0731
257550005
ICD-10-CM Version 2010
T78.40
intolerance to substance
Description

intolerance to substance

Data type

string

Alias
UMLS CUI
C1744706
peroxisome
Description

peroxisome

Data type

string

Alias
UMLS CUI
C0752063
SNOMED CT 2010_0731
11191006
Fenofibrate (substance)
Description

Fenofibrate

Data type

string

Alias
UMLS CUI
C0033228
SNOMED CT 2010_0731
386879008
Metformin (substance)
Description

Metformin

Data type

string

Alias
UMLS CUI
C0025598
SNOMED CT 2010_0731
372567009
LOINC Version 232
MTHU016062
Pioglitazone hydrochloride
Description

Actos

Data type

string

Alias
UMLS CUI
C0872972
SNOMED CT 2010_0731
116097005
Rosiglitazone maleate
Description

Avandia

Data type

string

Alias
UMLS CUI
C0795660
SNOMED CT 2010_0731
116096001
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Description

statin

Data type

string

Alias
UMLS CUI
C0360714
SNOMED CT 2010_0731
372912004
Myopathy
Description

Myopathy

Data type

string

Alias
UMLS CUI
C0026848
SNOMED CT 2010_0731
129565002
MedDRA 13.1
10028641
ICD-10-CM Version 2010
G72.9
ICD-9-CM Version 2011
359.9
Abnormalities, Drug-Induced
Description

Abnormalities, Drug-Induced

Data type

string

Alias
UMLS CUI
C0000771
Creatine Kinase
Description

Creatine Kinase

Data type

string

Alias
UMLS CUI
C0010287
SNOMED CT 2010_0731
75828004
LOINC Version 232
MTHU006937
Elevated liver enzyme levels
Description

Elevated liver enzyme levels

Data type

string

Alias
UMLS CUI
C0857093
MedDRA 13.1
10014480
Neutropenia
Description

Neutrophil count decreased

Data type

string

Alias
UMLS CUI
C0853697
MedDRA 13.1
10029366
CTCAE Version 4.03
E12198
Creatinine abnormal NOS
Description

Creatinine abnormal

Data type

string

Alias
UMLS CUI
C0740471
MedDRA 13.1
10011359
Clinical study
Description

Clinical Research

Data type

string

Alias
UMLS CUI
C0008972
Physical examination procedure
Description

Physical Examination

Data type

string

Alias
UMLS CUI
C0031809
SNOMED CT 2010_0731
5880005
MedDRA 13.1
10034986
LOINC Version 232
MTHU028014
ICD-9-CM Version 2011
89.7
Laboratory test
Description

Laboratory Procedures

Data type

string

Alias
UMLS CUI
C0022885
SNOMED CT 2010_0731
15220000
MedDRA 13.1
10059938
Electrocardiogram
Description

ECG

Data type

string

Alias
UMLS CUI
C1623258
SNOMED CT 2010_0731
46825001
MedDRA 13.1
10014084
patient safety
Description

patient safety

Data type

string

Alias
UMLS CUI
C1113679

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
Age
Item
Men or women who are >=18 years of age
boolean
informed consent
Item
Provision of a written informed consent
boolean
Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a method of birth control
Item
Female patients: postmenopausal, hysterectomized, or if of childbearing potential, using a reliable method of birth control
boolean
type 2 diabetes
Item
Diagnosed with type 2 diabetes
boolean
Treatment with diet alone or with a single oral antidiabetic agent or two oral antidiabetic agents
Item
Treated with diet alone or treatment with a single oral antidiabetic agent or low doses of two oral antidiabetic agents
boolean
Item Group
Exclusion Criteria
Type 1 diabetes
Item
Type 1 diabetes
boolean
NYHA Class III or IV
Item
New York Heart Association heart failure Class III or IV
boolean
Treatment with insulin
Item
Treatment with chronic insulin
boolean
hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist, fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
Item
History of hypersensitivity or intolerance to any peroxisome proliferator-activated receptor agonist (like Actos or Avandia), fenofibrate, metformin or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin)
boolean
drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia
Item
History of drug-induced myopathy or drug-induced creatine kinase elevation, liver enzyme elevations, neutropenia (low white blood cells)
boolean
Creatinine levels abnormal
Item
Creatinine levels above the normal range
boolean
Received any investigational product in other clinical studies
Item
Received any investigational product in other clinical studies within 12 weeks
boolean
Any clinically significant abnormality, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study
Item
Any clinically significant abnormality identified on physical examination, laboratory tests or electrocardiogram, which in the judgment of the investigator would compromise the patient's safety or successful participation in the clinical study
boolean
Item Group
Medical Concepts
Age
Item
Age
integer
C0001779 (UMLS CUI)
397669002 (SNOMED CT 2010_0731)
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
Informed Consent
Item
Informed Consent
string
C0021430 (UMLS CUI)
Postmenopause
Item
Postmenopausal period
string
C0206159 (UMLS CUI)
10051775 (MedDRA 13.1)
Hysterectomy
Item
Hysterectomy
string
C0020699 (UMLS CUI)
236886002 (SNOMED CT 2010_0731)
10021151 (MedDRA 13.1)
Contraception
Item
Contraception
string
C0700589 (UMLS CUI)
146680009 (SNOMED CT 2010_0731)
10010808 (MedDRA 13.1)
Diabetes mellitus type 2
Item
Diabetes Mellitus, Non-Insulin-Dependent
string
C0011860 (UMLS CUI)
44054006 (SNOMED CT 2010_0731)
10012613 (MedDRA 13.1)
E08-E13 (ICD-10-CM Version 2010)
Diet
Item
Diet
string
C0012155 (UMLS CUI)
41829006 (SNOMED CT 2010_0731)
Anti-diabetic Agent
Item
Anti-diabetic Agent
string
C0935929 (UMLS CUI)
373245004 (SNOMED CT 2010_0731)
Diabetes mellitus type 1
Item
Diabetes Mellitus, Insulin-Dependent
string
C0011854 (UMLS CUI)
46635009 (SNOMED CT 2010_0731)
10067584 (MedDRA 13.1)
MTHU020217 (LOINC Version 232)
E10 (ICD-10-CM Version 2010)
Heart failure
Item
Heart failure
string
C0018801 (UMLS CUI)
155374007 (SNOMED CT 2010_0731)
10019279 (MedDRA 13.1)
428 (ICD-9-CM Version 2011)
E10124 (CTCAE Version 4.03)
NYHA Class III
Item
New York Heart Association Class III
string
C1319795 (UMLS CUI)
420913000 (SNOMED CT 2010_0731)
10064081 (MedDRA 13.1)
NYHA Class IV
Item
New York Heart Association Class IV
string
C1319796 (UMLS CUI)
422293003 (SNOMED CT 2010_0731)
10064082 (MedDRA 13.1)
Therapeutic Insulin
Item
Therapeutic Insulin
string
C0557978 (UMLS CUI)
Insulin
Item
Insulin
string
C0021641 (UMLS CUI)
67866001 (SNOMED CT 2010_0731)
MTHU002108 (LOINC Version 232)
chronic
Item
chronic
string
C0205191 (UMLS CUI)
90734009 (SNOMED CT 2010_0731)
Allergy
Item
Hypersensitivity
string
C0020517 (UMLS CUI)
257550005 (SNOMED CT 2010_0731)
T78.40 (ICD-10-CM Version 2010)
intolerance to substance
Item
intolerance to substance
string
C1744706 (UMLS CUI)
peroxisome
Item
peroxisome
string
C0752063 (UMLS CUI)
11191006 (SNOMED CT 2010_0731)
Fenofibrate
Item
Fenofibrate (substance)
string
C0033228 (UMLS CUI)
386879008 (SNOMED CT 2010_0731)
Metformin
Item
Metformin (substance)
string
C0025598 (UMLS CUI)
372567009 (SNOMED CT 2010_0731)
MTHU016062 (LOINC Version 232)
Actos
Item
Pioglitazone hydrochloride
string
C0872972 (UMLS CUI)
116097005 (SNOMED CT 2010_0731)
Avandia
Item
Rosiglitazone maleate
string
C0795660 (UMLS CUI)
116096001 (SNOMED CT 2010_0731)
statin
Item
Hydroxymethylglutaryl-CoA Reductase Inhibitors
string
C0360714 (UMLS CUI)
372912004 (SNOMED CT 2010_0731)
Myopathy
Item
Myopathy
string
C0026848 (UMLS CUI)
129565002 (SNOMED CT 2010_0731)
10028641 (MedDRA 13.1)
G72.9 (ICD-10-CM Version 2010)
359.9 (ICD-9-CM Version 2011)
Abnormalities, Drug-Induced
Item
Abnormalities, Drug-Induced
string
C0000771 (UMLS CUI)
Creatine Kinase
Item
Creatine Kinase
string
C0010287 (UMLS CUI)
75828004 (SNOMED CT 2010_0731)
MTHU006937 (LOINC Version 232)
Elevated liver enzyme levels
Item
Elevated liver enzyme levels
string
C0857093 (UMLS CUI)
10014480 (MedDRA 13.1)
Neutrophil count decreased
Item
Neutropenia
string
C0853697 (UMLS CUI)
10029366 (MedDRA 13.1)
E12198 (CTCAE Version 4.03)
Creatinine abnormal
Item
Creatinine abnormal NOS
string
C0740471 (UMLS CUI)
10011359 (MedDRA 13.1)
Clinical Research
Item
Clinical study
string
C0008972 (UMLS CUI)
Physical Examination
Item
Physical examination procedure
string
C0031809 (UMLS CUI)
5880005 (SNOMED CT 2010_0731)
10034986 (MedDRA 13.1)
MTHU028014 (LOINC Version 232)
89.7 (ICD-9-CM Version 2011)
Laboratory Procedures
Item
Laboratory test
string
C0022885 (UMLS CUI)
15220000 (SNOMED CT 2010_0731)
10059938 (MedDRA 13.1)
ECG
Item
Electrocardiogram
string
C1623258 (UMLS CUI)
46825001 (SNOMED CT 2010_0731)
10014084 (MedDRA 13.1)
patient safety
Item
patient safety
string
C1113679 (UMLS CUI)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial